Peptide Therapy
Short-chain amino-acid sequences selected for their signalling effects on specific physiological pathways, prescribed only after individualized diagnostic work-up.
What it is & how it works
Peptide therapy uses specific short-chain amino-acid sequences selected for their signalling effects on particular physiological pathways — for example, growth-hormone secretagogues intended to support recovery and body composition, or peptides studied for metabolic or tissue-repair signalling. Peptides act on defined receptor pathways, distinguishing them mechanistically from broader hormone replacement.
How it's done
Typically administered by subcutaneous injection, either self-administered at home after training or given in-clinic, with dosing and specific peptide selection individualized following diagnostic work-up. Protocols generally run in cycles of weeks to months, with periodic review and lab monitoring.
Conditions it treats
Why Unfold Longevity
Prescribed only following individualized diagnostic work-up and reviewed against current regulatory status, reflecting Unfold Longevity's evidence-bounded approach of not offering a service ahead of its approval status.
Evidence & safety
Prescribed individually following diagnostic work-up. Its use for Sarcopenia is provisional, and broader recovery use is offered only where regulatory status permits.
Related questions
Only where a specific peptide's regulatory status in India has been confirmed and it has been individually prescribed following diagnostic work-up. Peptides without confirmed regulatory clearance for the intended use are not offered, booked, or discussed as available.
In general use, peptides are short amino-acid chains studied for effects on specific physiological pathways, such as growth-hormone secretagogues studied for recovery and body composition, but regulatory oversight and clinical evidence vary widely by peptide and jurisdiction. Some peptides sold online for performance or longevity use are not approved drugs; the US FDA has flagged some such compounds as carrying safety risks due to limited human safety data and variable product purity, which is why unconfirmed peptides are not used here.